Dr. Jane Hoppin, Professor – NC State University
The IARC process of evaluating potential carcinogens: recent findings for PFOA and PFOS
12 events found.
Spring
Events
-
-
Toxicology Auditorium 2104
-
Dr. Joshua Snyder, Associate Professor – Duke University
Toxicology Auditorium 2104Modeling the occult tumorigenic phase reveals ecological mechanisms of tumor initiation and metastasis
-
-
-
CHHE 8th Annual Symposium
Talley Student Union 2610 Cates Ave, Raleigh, NC, United StatesPerinatal Environmental Exposures and Later Life Disease: Biological Targets and Mechanisms Keynote Speakers: Antonia Calafat, CDC - Chemical Exposures: What Does Biomonitoring Tell Us? Randy Jirtle, CHHE - Past, present and future of FOAD Talley Student Union, Piedmont/Mountains Ballroom 2610 Cates Ave, Raleigh, NC 27606 Registration: tinyurl.com/perinatalCHHE
-
Dr. Jesse Goodrich, Assistant Professor – University of Southern California
Toxicology Auditorium 2104Emerging Carcinogens: Using Multiomics to Interrogate the Role of PFAS in Liver Cancer Development
-
-
Dr. Cindy Moylan, Associate Professor – Duke University
Toxicology Auditorium 2104Connecting MASLD. Liver Cancer and our Environment. How did I (we) get here?
-
Dr. Phillip Clapp. Assistant Professor – University of North Carolina
Toxicology Auditorium 2104Puff or Pass? Assessing the Health Risks of E-Cigarettes and Vaping Products in a Rapidly Evolving Industry
-
Dr. Kristen Rapazzo – EPA
Toxicology Auditorium 2104From science to policy: air pollution, reproduction, and development
-
-
Dr. Jean Harry – NIEHS
Toxicology Auditorium 2104Strobilurins - Are they the next mitochondrial toxicant of concern for neurotoxicity? If so, how?
-
Dr. David Volz, Professor – UC-Riverside
Toxicology Auditorium 2104Human Exposure and Health Effects of Organo-Phosphate Based Flame Retardants
-
Dr. Ryan Vetreno, Assistant Professor – University of North Carolina
Toxicology Auditorium 2104No REST for the weak: Neuroimmune and epigenetic mechanisms underlying reversible suppression of cholinergic neuron phenotype
-
Dr. Gayathri Devi, Duke University
Toxicology Auditorium 2104One Network: Precision Health and Community Partnerships to Address Breast Cancer Health Disparity
